Associated Banc-Corp’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,593
| Closed | -$240K | – | 330 |
|
|
2024
Q2 | $240K | Buy |
2,593
+22
| +0.9% | +$2.03K | 0.01% | 299 |
|
|
2024
Q1 | $246K | Buy |
+2,571
| New | +$246K | 0.01% | 294 |
|
|
2023
Q3 | – | Sell |
-2,571
| Closed | -$243K | – | 309 |
|
|
2023
Q2 | $243K | Hold |
2,571
| – | – | 0.01% | 286 |
|
|
2023
Q1 | $213K | Buy |
+2,571
| New | +$213K | 0.01% | 295 |
|
|
2022
Q4 | – | Sell |
-2,571
| Closed | -$212K | – | 306 |
|
|
2022
Q3 | $212K | Hold |
2,571
| – | – | 0.01% | 283 |
|
|
2022
Q2 | $244K | Hold |
2,571
| – | – | 0.01% | 279 |
|
|
2022
Q1 | $302K | Hold |
2,571
| – | – | 0.01% | 276 |
|
|
2021
Q4 | $333K | Hold |
2,571
| – | – | 0.01% | 269 |
|
|
2021
Q3 | $291K | Hold |
2,571
| – | – | 0.01% | 275 |
|
|
2021
Q2 | $267K | Buy |
+2,571
| New | +$267K | 0.01% | 285 |
|
|
2021
Q1 | – | Sell |
-3,487
| Closed | -$318K | – | 484 |
|
|
2020
Q4 | $318K | Buy |
3,487
+2,510
| +257% | +$229K | 0.01% | 311 |
|
|
2020
Q3 | $78K | Buy |
977
+112
| +13% | +$8.94K | ﹤0.01% | 361 |
|
|
2020
Q2 | $60K | Buy |
865
+610
| +239% | +$42.3K | ﹤0.01% | 367 |
|
|
2020
Q1 | $16K | Sell |
255
-2,346
| -90% | -$147K | ﹤0.01% | 381 |
|
|
2019
Q4 | $202K | Buy |
+2,601
| New | +$202K | 0.01% | 302 |
|